India, Sept. 8 -- Online pharmacy unicorn PharmEasy managed to cut its net losses for the second consecutivefiscal year in FY25, reducing its burn for the fiscal by 40% to INR 1,516.8 Cr. The decline in the company's net losses comes on the back of a substantial decline in exceptional item losses for it in the fiscal.

In FY25, PharmEasy parent API Holdings registered an exceptional item loss of INR 296.5 Cr, down 71% from INR 1,027 Cr in FY24.

While the company marked a significant improvement in its bottom line, its top line remained almost flat. Operating revenue for FY25 stood at INR 5,872.1 Cr, up 3.6% from INR 5,664.2 Cr recorded in the previous fiscal year. Including an other income of INR 107.9 Cr, its total income stood at INR 5...